| Form of presentation | Articles in international journals and collections |
| Year of publication | 2015 |
| Язык | английский |
|
Lombardi Vinsent Klifford , author
Khaybullina Svetlana Francevna, author
|
| Bibliographic description in the original language |
Lombardi V.C. Plasmacytoid dendritic cells, a role in neoplastic prevention and progression / V.C. Lombardi, S.F. Khaiboullina, A.A. Rizvanov // European Journal of Clinical Investigation. – 2015. – Vol.45 (Issue Supplement s1). – DOI: 10.1111/eci.12363. |
| Annotation |
Plasmacytoid dendritic cells (pDCs) are multifunctional bone-marrow-derived immune cells that are key players in bridging the innate and adaptive immune systems. Activation of pDCs through toll-like receptor agonists has proven to be an effective treatment for some neoplastic disorders. |
| Keywords |
Cancer; immunity; pDC; plasmacytoid dendritic cells; tolerance; tumour |
| The name of the journal |
European Journal of Clinical Investigation
|
| URL |
http://www.ncbi.nlm.nih.gov/pubmed/25524580 |
| Please use this ID to quote from or refer to the card |
https://repository.kpfu.ru/eng/?p_id=113216&p_lang=2 |
Full metadata record  |
| Field DC |
Value |
Language |
| dc.contributor.author |
Lombardi Vinsent Klifford |
ru_RU |
| dc.contributor.author |
Khaybullina Svetlana Francevna |
ru_RU |
| dc.date.accessioned |
2015-01-01T00:00:00Z |
ru_RU |
| dc.date.available |
2015-01-01T00:00:00Z |
ru_RU |
| dc.date.issued |
2015 |
ru_RU |
| dc.identifier.citation |
Lombardi V.C. Plasmacytoid dendritic cells, a role in neoplastic prevention and progression / V.C. Lombardi, S.F. Khaiboullina, A.A. Rizvanov // European Journal of Clinical Investigation. – 2015. – Vol.45 (Issue Supplement s1). – DOI: 10.1111/eci.12363. |
ru_RU |
| dc.identifier.uri |
https://repository.kpfu.ru/eng/?p_id=113216&p_lang=2 |
ru_RU |
| dc.description.abstract |
European Journal of Clinical Investigation |
ru_RU |
| dc.description.abstract |
Plasmacytoid dendritic cells (pDCs) are multifunctional bone-marrow-derived immune cells that are key players in bridging the innate and adaptive immune systems. Activation of pDCs through toll-like receptor agonists has proven to be an effective treatment for some neoplastic disorders. |
ru_RU |
| dc.language.iso |
ru |
ru_RU |
| dc.subject |
|
ru_RU |
| dc.title |
Plasmacytoid dendritic cells, a role in neoplastic prevention and progression |
ru_RU |
| dc.type |
Articles in international journals and collections |
ru_RU |
|